Martim de Almeida Nóbrega Correia Pascoal1, Nuno Bernardo Malta Dos Santos2, António Manuel Godinho Completo3, Gustavo Vicentis de Oliveira Fernandes4,5. 1. Integrated Master in Dental Medicine, Faculty of Dental Medicine, Universidade Católica Portuguesa, Viseu, Portugal. 2. Periodontics Department, Center for Interdisciplinary Research in Health (CIIS), Faculty of Dental Medicine, Universidade Católica Portuguesa, Viseu, Portugal. 3. TEMA, Universidade de Aveiro, Aveiro, Portugal. 4. Periodontics Department, Center for Interdisciplinary Research in Health (CIIS), Faculty of Dental Medicine, Universidade Católica Portuguesa, Viseu, Portugal. gustfernandes@gmail.com. 5. Implantology and Biomaterials Department, Faculty of Dental Medicine, Universidade Católica Portuguesa, Quinta da Alagoa Ave., 225 - 1 DT, 3500-606, Viseu, Portugal. gustfernandes@gmail.com.
Abstract
BACKGROUND: Since the leucocyte-platelet rich fibrin (L-PRF) was published in 2001, many studies have been developed, analyzing its properties, and also verifying new possibilities to improve it. Thereby, it emerges the advanced-platelet rich fibrin (A-PRF) with a protocol that optimizes the properties obtained by the L-PRF. Nonetheless, there is a gap in the literature to landmark the evolutive process concerning the mechanical properties in specific the resistance to tensile strength which consequently may influence the time for membrane degradation. Thus, this study had the goal to compare the resistance to the traction of membranes produced with the original L-PRF and A-PRF protocols, being the first to this direct comparison. FINDINGS: The harvest of blood from a healthy single person, with no history of anticoagulant usage. We performed the protocols described in the literature, within a total of 13 membranes produced for each protocol (n = 26). Afterward, the membranes were prepared and submitted to a traction test assessing the maximal and the average traction achieved for each membrane. The data were analyzed statistically using the unpaired t test. Regarding average traction, A-PRF obtained a value of 0.0288 N mm-2 and L-PRF 0.0192 N mm-2 (p < 0.05 using unpaired t test). For maximal traction, A-PRF obtained 0.0752 N mm-2 and L-PRF 0.0425 N mm-2 (p < 0.05 using unpaired t test). CONCLUSION: With this study, it was possible to conclude that indeed A-PRF has a significative higher maximal traction score and higher average traction compared to L-PRF, indicating that it had a higher resistance when two opposing forces are applied.
BACKGROUND: Since the leucocyte-platelet rich fibrin (L-PRF) was published in 2001, many studies have been developed, analyzing its properties, and also verifying new possibilities to improve it. Thereby, it emerges the advanced-platelet rich fibrin (A-PRF) with a protocol that optimizes the properties obtained by the L-PRF. Nonetheless, there is a gap in the literature to landmark the evolutive process concerning the mechanical properties in specific the resistance to tensile strength which consequently may influence the time for membrane degradation. Thus, this study had the goal to compare the resistance to the traction of membranes produced with the original L-PRF and A-PRF protocols, being the first to this direct comparison. FINDINGS: The harvest of blood from a healthy single person, with no history of anticoagulant usage. We performed the protocols described in the literature, within a total of 13 membranes produced for each protocol (n = 26). Afterward, the membranes were prepared and submitted to a traction test assessing the maximal and the average traction achieved for each membrane. The data were analyzed statistically using the unpaired t test. Regarding average traction, A-PRF obtained a value of 0.0288 N mm-2 and L-PRF 0.0192 N mm-2 (p < 0.05 using unpaired t test). For maximal traction, A-PRF obtained 0.0752 N mm-2 and L-PRF 0.0425 N mm-2 (p < 0.05 using unpaired t test). CONCLUSION: With this study, it was possible to conclude that indeed A-PRF has a significative higher maximal traction score and higher average traction compared to L-PRF, indicating that it had a higher resistance when two opposing forces are applied.
Authors: Eduardo Borie; Daniel García Oliví; Iara Augusta Orsi; Katia Garlet; Benjamín Weber; Víctor Beltrán; Ramón Fuentes Journal: Int J Clin Exp Med Date: 2015-05-15
Authors: Luigi Fabrizio Rodella; Gaia Favero; Ramon Boninsegna; Barbara Buffoli; Mauro Labanca; Giorgio Scarì; Luigi Sacco; Tiziano Batani; Rita Rezzani Journal: Microsc Res Tech Date: 2011-08 Impact factor: 2.769
Authors: Shahram Ghanaati; Patrick Booms; Anna Orlowska; Alica Kubesch; Jonas Lorenz; Jim Rutkowski; Constantin Landes; Robert Sader; Cj Kirkpatrick; Joseph Choukroun Journal: J Oral Implantol Date: 2014-12 Impact factor: 1.779
Authors: David M Dohan Ehrenfest; Tomasz Bielecki; Ryo Jimbo; Giovanni Barbé; Marco Del Corso; Francesco Inchingolo; Gilberto Sammartino Journal: Curr Pharm Biotechnol Date: 2012-06 Impact factor: 2.837
Authors: Nelson R Pinto; Matias Ubilla; Yelka Zamora; Verónica Del Rio; David M Dohan Ehrenfest; Marc Quirynen Journal: Platelets Date: 2017-07-20 Impact factor: 3.862
Authors: Mara Simões-Pedro; Pedro Maria B P S Tróia; Nuno Bernardo Malta Dos Santos; António M G Completo; Rogerio Moraes Castilho; Gustavo Vicentis de Oliveira Fernandes Journal: Polymers (Basel) Date: 2022-03-29 Impact factor: 4.329
Authors: Karol Alí Apaza Alccayhuaman; Stefan Tangl; Stéphane Blouin; Markus A Hartmann; Patrick Heimel; Ulrike Kuchler; Jung-Seok Lee; Reinhard Gruber Journal: Biomedicines Date: 2021-06-25